Targeting chondrocytes for arresting bony fusion in ankylosing spondylitis
Current treatments cannot significantly alleviate the radiographic progression in ankylosing spondylitis (AS), which results in joints stiffness and bony fusion of AS. Smo inhibitor sonidegib retards the pathological new bone formation in AS through targeting dysfunctional chondrogenesis.
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/12886a3b76044df8b6656dcdbe796a6e |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|